Neuroinflammation has been shown to play a crucial role in the development of Alzheimer’s disease (AD) and also has an association with amyloid-β (Aβ) plaques, a hallmark of this disease. Physical exercise has emerged as an alternative treatment for pathological impairment in AD. In light of this evidence, together with the fact that the hippocampus is one of the first structures to be affected in AD, we analyzed hippocampal changes in Aβ load, inflammatory responses, and locomotor activity in transgenic APP/PS1 mouse model for AD submitted to a resistance exercise (RE) program. One month after the start of the RE program, the locomotor hyperactivity related to AD behavior was reduced and microglia recruitment was increased, which in turn may have contributed to the decrease in the volume of Aβ plaques. In addition, the RE program restored the levels of IL-1α, IL-4, and IL-6 cytokines to control levels. Our study indicates that RE has beneficial effects on the locomotor behavior, amyloid burden, and inflammation of AD pathology and can therefore be used as a therapy to improve the clinical symptoms and neurophysiological alterations in AD. To the best of our knowledge, this is the first study to use a resistance exercise program in transgenic AD model.
KarranE, De StrooperB (2016) The amyloid cascade hypothesis: Are we poised for success or failure?J Neurochem139, 237–252.
2.
SelkoeDJ, HardyJ (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med8, 595–608.
3.
KametaniF, HasegawaM (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s disease. Front Neurosci12, 1–11.
4.
HamelinL, LagardeJ, DorothéeG, LeroyC, LabitM, ComleyRA, De SouzaLC, CorneH, DauphinotL, BertouxM, DuboisB, GervaisP, ColliotO, PotierMC, BottlaenderM, SarazinM (2016) Early and protective microglial activation in Alzheimer’s disease: A prospective study using 18F-DPA-714 PET imaging. Brain139, 1252–1264.
5.
SpangenbergEE, GreenKN (2017) Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models. Brain Behav Immun61, 1–11.
6.
ZhengC, ZhouXW, WangJZ (2016) The dual roles of cytokines in Alzheimer’s disease: Update on interleukins, TNF-α, TGF-β and IFN-γ. Transl Neurodegener5, 1–15.
7.
SochockaM, DinizBS, LeszekJ (2017) Inflammatory response in the CNS: Friend or foe?Mol Neurobiol54, 8071–8089.
8.
HickmanS, IzzyS, SenP, MorsettL, El KhouryJ (2018) Microglia in neurodegeneration. Nat Neurosci21, 1359–1369.
9.
TangY, LeW (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol53, 1181–1194.
10.
RajendranL, PaolicelliRC (2018) Microglia-mediated synapse loss in Alzheimer’s disease. J Neurosci38, 2911–2919.
11.
KennedyG, HardmanRJ, MacPhersonH, ScholeyAB, PipingasA (2016) How does exercise reduce the rate of age-associated cognitive decline? A review of potential mechanisms. J Alzheimers Dis55, 1–18.
12.
KellyM (2018) Exercise-induced modulation of neuroinflammation in models of Alzheimer’s disease. Adv Neurobiol4, 81–94.
13.
LourencoMV, FrozzaRL, de FreitasGB, ZhangH, KincheskiGC, RibeiroFC, GonçalvesRA, ClarkeJR, BeckmanD, StaniszewskiA, BermanH, GuerraLA, Forny-GermanoL, MeierS, WilcockDM, de SouzaJM, Alves-LeonS, PradoVF, PradoMAM, AbisambraJF, Tovar-MollF, MattosP, ArancioO, FerreiraST, De FeliceFG (2019) Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med25, 165–175.
14.
CassilhasRC, VianaVAR, GrassmannV, SantosRT, SantosRF, TufikS, MelloMT (2007) The impact of resistance exercise on the cognitive function of the elderly. Exerc39, 1401–1407.
15.
Chodzko-ZajkoWJ, ProctorDN, Fiatarone SinghMA, MinsonCT, NiggCR, SalemGJ, SkinnerJS (2009) Exercise and physical activity for older adults. Med Sci Sports Exerc41, 1510–1530.
16.
GaruffiM, LuizJ, CostaR, SthephanyS, HernándezS, VitalTM, SteinAM, GomesJ, StellaF (2013) Effects of resistance training on the performance of activities of daily living in patients with Alzheimer’s disease. Geriatr Gerontol Int13, 322–328.
17.
StricklandJC, SmithMA (2016) Animal models of resistance exercise and their application to neuroscience research. J Neurosci Methods273, 191–200.
18.
LalondeR, FukushiK, StrazzielleZ (2012) APP transgenic mice for modelling behavioral and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev36, 1357–1375.
Serrano-PozoA, FroschMP, MasliahE, HymanBT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med1, 1–23.
21.
LimaMGP, SchimiditHL, GarciaA, DaréLR, CarpesFP, IzquierdoI, Mello-CarpesPB (2018) Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity. Proc Natl Acad Sci U S A115, E2403–E2409.
22.
CassilhasRC, LeeKS, FernandesJ, OliveiraMGM, TufikS, MeeusenR, De MelloMT (2012) Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms. Neuroscience212, 309–317.
23.
Wuo-SilvaR, FukushiroDF, HollaisAW, Santos-BaldaiaR, Mári-KawamotoE, BerroLF, YokoyamaTS, Lopes-SilvaLB, BizerraCS, Procópio-SouzaR, HashiguchiD, FigueiredoLA, CostaJL, Frussa-FilhoR, LongoBM (2016) Modafinil induces rapid-onset behavioral sensitization and cross-sensitization with cocaine in mice: Implications for the addictive potential of modafinil. Front Pharmacol7, 1–10.
24.
PaxinosG, FranklinK (2001) The mouse brain in stereotaxic coordinates, Academic Press, Sydney.
25.
GundersenHJG (2002) The smooth fractionator. J Microsc207, 191–210.
26.
DavalosD, GrutzendlerJ, YangG, KimJV, ZuoY, JungS, LittmanDR, DustinML, GanWB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci8, 752–758.
27.
GundersenHJG, JensenEBV, KiêuK, NielsenJ (1999) The efficiency of systematic sampling in stereology - reconsidered. J Microsc193, 199–211.
Gillette-GuyonnetS, NourhashemiF, AndrieuS, de GlisezinskiI, OussetPJ, RiviereD, AlbaredeJL, VellasB (2000) Weight loss in Alzheimer disease. Am J Clin Nutr71, 637S–642S.
30.
GuérinO, AndrieuS, SchneiderSM, CortesF, CantetC, Gillette-GuyonnetS, VellasB (2009) Characteristics of Alzheimer’s disease patients with a rapid weight loss during a six-year follow-up. Clin Nutr28, 141–146.
31.
SotoME, SecherM, Gillette-GuyonnetS, Abellan van KanG, AndrieuS, NourhashemiF, RollandY, VellasB (2012) Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer’s disease. J Alzheimers Dis28, 647–654.
32.
CovaI, ClericiF, RossiA, CucumoV, GhirettiR, MaggioreL, PomatiS, GalimbertiD, ScarpiniE, MarianiC, CaraccioloB (2016) Weight loss predicts progression of mild cognitive impairment to Alzheimer’s disease. PLoS One11, 1–12.
HooijmansCR, Van der ZeeCEEM, DederenPJ, BrouwerKM, ReijmerYD, van GroenT, BroersenLM, LütjohannD, HeerschapA, KiliaanAJ (2009) DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis33, 482–498.
35.
TimmerNM, van DijkL, van der ZeeCEEM, KiliaanA, de WaalRM, VerbeekMM (2010) Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels. Neurobiol Dis40, 340–347.
36.
GaoJ, ChenY, SuD, MarshallC, XiaoM (2018) Depressive- and anxiety-like phenotypes in young adult APPSwe/PS1dE9 transgenic mice with insensitivity to chronic mild stress. Behav Brain Res353, 114–123.
37.
HeroldF, TörpelA, SchegaL, MüllerNG (2019) Functional and/or structural brain changes in response to resistance exercises and resistance training lead to cognitive improvements - a systematic review. Eur Rev Aging Phys Act16, 10.
38.
KjølhedeT, SiemonsenS, WenzelD, StellmannJP, RinggaardS, PedersenBG, StenagerE, PetersenT, VissingK, HeesenC, DalgasU (2018) Can resistance training impact MRI outcomes in relapsingremitting multiple sclerosis?Mult Scler24, 1356–1365.
39.
NagamatsuLS, HandyTC, HsuCL, VossM, Liu-AmbroseT (2012) Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment. Arch Intern Med172, 666–668.
40.
TsaiC-L, PaiM-C, UkropecJ, UkropcováB (2019) Distinctive effects of aerobic and resistance exercise modes on neurocognitive and biochemical changes in individuals with mild cognitive impairment. Curr Alzheimer Res16, 316–332.
41.
ÖzbeyliD, SariG, ÖzkanN, KarademirB, YükselM, Çilingir KayaÖT, Kasimay ÇakirÖ (2017) Protective effects of different exercise modalities in an Alzheimer’s disease-like model. Behav Brain Res328, 159–177.
42.
AlkadhiKA, DaoAT (2018) Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer’s disease. Mol Cell Neurosci86, 25–29.
43.
ZhangX, FuZ, MengL, HeM, ZhangZ (2018) The early events that initiate β-amyloid aggregation in Alzheimer’s disease. Front Aging Neurosci10, 1–13.
44.
BrownBM, PeifferJ, Rainey-SmithSR (2019) Exploring the relationship between physical activity, beta-amyloid and tau: A narrative review. Ageing Res Rev50, 9–18.
45.
RyanSM, KellyÁM (2016) Exercise as a pro-cognitive, pro-neurogenic and anti-inflammatory intervention in transgenic mouse models of Alzheimer’s disease. Ageing Res Rev27, 77–92.
46.
KeHC, HuangHJ, LiangKC, Hsieh-LiHM (2011) Selective improvement of cognitive function in adult and aged APP/PS1 transgenic mice by continuous non-shock treadmill exercise. Brain Res1403, 1–11.
47.
Wyss-CorayT, YanF, LinAH, LambrisJD, AlexanderJJ, QuiggRJ, MasliahE (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer’s mice. Proc Natl Acad Sci U S A99, 10837–10842.
BaikSH, KangS, SonSM, Mook-JungI (2016) Microglia contributes to plaque growth by cell death due to uptake of amyloid-β in the brain of Alzheimer’s disease mouse model. Glia64, 2274–2290.
50.
YinF, BoverisA, CadenasE (2014) Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal20, 353–371.
51.
BaikSH, KangS, LeeW, ChoiH, ChungS, KimJI, Mook-JungI (2019) A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer’s disease. Cell Metab30, 493–507.
52.
SteffenJ, StenzelJ, IbrahimS, PahnkeJ (2018) Short-term effects of microglia-specific mitochondrial dysfunction on amyloidosis in transgenic models of Alzheimer’s disease. J Alzheimers Dis65, 465–474.
RaefskySM, MattsonMP (2017) Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radic Biol Med102, 203–216.
55.
Fiuza-LucesC, ValenzuelaPL, Laine-MenéndezS, Fernández-de la TorreM, Bermejo-GómezV, Rufián-VázquezL, ArenasJ, MartínMA, LuciaA, MoránM (2019) Physical exercise and mitochondrial disease: Insights from a mouse model. Front Neurol10, 790.
56.
DietrichMO, AndrewsZB, HorvathTL (2008) Exercise-induced synaptogenesis in the hippocampus is dependent on UCP2-regulated mitochondrial adaptation. J Neurosci28, 10766–10771.
57.
Marques-AleixoI, Santos-AlvesE, BalçaMM, Rizo-RocaD, MoreiraPI, OliveiraPJ, MagalhãesJ, AscensãoA (2015) Physical exercise improves brain cortex and cerebellum mitochondrial bioenergetics and alters apoptotic, dynamic and auto(mito)phagy markers. Neuroscience301, 480–495.
58.
ParkHS, ChoHS, KimTW (2018) Physical exercise promotes memory capability by enhancing hippocampal mitochondrial functions and inhibiting apoptosis in obesity-induced insulin resistance by high fat diet. Metab Brain Dis33, 283–292.
SuF,
BaiFZhangZ (2016) Inflammatory cytokines and Alzheimer’s disease: A review from the perspective of genetic polymorphisms. Neurosci Bull32, 469–480.
61.
WestPK, ViengkhouB, CampbellIL, HoferMJ (2019) Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease. Glia10, 1821–1841.
62.
Di PaoloNC, ShayakhmetovDM (2016) Interleukin 1α and the inflammatory process. Nat Immunol17, 906–913.
63.
MalikA, KannegantiTD (2018) Function and regulation of IL-1α in inflammatory diseases and cancer. Immunol Rev281, 124–137.
64.
LattaCH, SudduthTL, WeekmanEM, BrothersHM, AbnerEL, PopaGJ, MendenhallMD, Gonzalez-OregonF, BraunK, WilcockDM (2015) Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice. J Neuroinflammation12, 1–13.
65.
CasellaG, ColomboF, FinardiA, DescampsH, Ill-RagaG, SpinelliA, PodiniP, BastoniM, MartinoG, MuzioL, FurlanR (2018) Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis. Mol Ther26, 2107–2118.
66.
VogelaarCF, MandalS, LerchS, BirknerK, KipnisJ, ZippF, NitschR, RaineCS, SchnatzA, BittnerS, BirkenstockJ, VogtJ, BühlerU (2018) Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation. Sci Transl Med10, 2304.
67.
KiyotaT, IngrahamKL, SwanRJ, JacobsenMT, AndrewsSJ, IkezuT (2012) AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice. Gene Ther19, 724–733.
